000 01275 a2200361 4500
005 20250512055649.0
264 0 _c19860724
008 198607s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.29.3.409
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShibl, A M
245 0 0 _aEvaluation of pefloxacin in experimental Escherichia coli meningitis.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMar 1986
300 _a409-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Infective Agents
_xmetabolism
650 0 4 _aCefotaxime
_xtherapeutic use
650 0 4 _aChloramphenicol
_xtherapeutic use
650 0 4 _aEscherichia coli Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMeningitis
_xdrug therapy
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aNorfloxacin
_xanalogs & derivatives
650 0 4 _aPefloxacin
650 0 4 _aRabbits
650 0 4 _aTime Factors
700 1 _aHackbarth, C J
700 1 _aSande, M A
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 29
_gno. 3
_gp. 409-11
856 4 0 _uhttps://doi.org/10.1128/AAC.29.3.409
_zAvailable from publisher's website
999 _c3527206
_d3527206